NDRA
ENDRA Life Sciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.47
+0.20 ▲ +6.12%
🌙 3월 13일 6:17 PM ET (한국 3/14 07:17)
$3.27
-0.20 ▼ -5.76%
| Index | - | P/E | - | EPS (ttm) | -13.39 | Insider Own | 47.59% | Shs Outstand | 0.00B | Perf Week | 3.27% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 29.89% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -3.88% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -1.23 | Inst Own | 6.16% | Short Float | 25.37% | Perf Quarter | -40.78% |
| Income | -0.01B | P/S | - | EPS this Y | 88.43% | Inst Trans | 10.87% | Short Ratio | 1.42 | Perf Half Y | -24.73% |
| Sales | 0.00B | P/B | 15.93 | EPS next 5Y | - | ROA | -154.83% | Short Interest | 0.15M | Perf YTD | -23.4% |
| Book/sh | 0.22 | P/C | 5.13 | EPS past 3/5Y | 81.97% 76.64% | ROE | -236.34% | 52W High | -70.99% ($11.96) | Perf Year | -10.03% |
| Cash/sh | 0.68 | P/FCF | - | Sales past 3/5Y | - | ROIC | -1409.93% | 52W Low | 19.66% ($2.90) | Perf 3Y | -99.95% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 98.86% | Gross Margin | - | Volatility(W/M) | 11.13% 12.56% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.41 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.31 | EPS Q/Q | 99.37% | Profit Margin | - | RSI (14) | 43.14 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.31 | Sales Q/Q | - | SMA20 | -4.95% ($3.65) | Beta | -0.07 | Target Price | $30 |
| Payout | - | Debt/Eq | 3.12 | Earnings | 11000000 | SMA50 | -13.49% ($4.01) | Rel Volume | 0.07 | Prev Close | $3.27 |
| Employees | 21 | LT Debt/Eq | 2.35 | EPS/Sales Surpr. | -7.69% - | SMA200 | -28.74% ($4.87) | Avg Volume(3M) | 0.11M | Price | $3.47 |
| IPO | 2017/6/30 | Option/Short | No/Yes | Trades | 1614 | Volume | 7,330 | Change | 6.12% |
뉴스 로딩 중...